Genomic Valley Biotech Ltd.
BSE: GVBL
Prev Close
43.08
Open Price
45.93
Volume
1,547
Today Low / High
44.85 / 45.93
52 WK Low / High
38.01 / 94
Range
43 - 47
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 45, reflecting a change of 1.92 (4.45682%). The expected target range on the BSE is 43 - 47. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Genomic Valley Biotech Ltd. Graph
Genomic Valley Biotech Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Genomic Valley Biotech Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 45.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 45.00 | 45.45 | 40.91 - 50.00 |
| 45.90 | 36.72 - 55.08 | ||
| 46.35 | 32.45 - 60.26 | ||
| Bearish Scenario | 45.00 | 44.55 | 40.10 - 49.01 |
| 44.10 | 35.28 - 52.92 | ||
| 43.65 | 30.56 - 56.75 |
Overview of Genomic Valley Biotech Ltd.
ISIN
INE574D01010
Industry
Biotechnology
Vol.Avg
1,929
Market Cap
125,234,500
Last Dividend
0
Official Website
IPO Date
DCF Diff
82.68
DCF
-40
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.84 Cr | 0.20 Cr | 0.64 Cr | 0.7614 | 0.00 Cr | 0.00 Cr | 0.44 Cr | 0.36 Cr | 1.17 | 0.44 Cr | 0.4219 |
| 2024-03-31 | 0.17 Cr | 0.00 Cr | 0.17 Cr | 1.0000 | 0.00 Cr | 0.05 Cr | 0.13 Cr | 0.02 Cr | 0.05 | 0.02 Cr | 0.0920 |
| 2023-03-31 | 2.72 Cr | 1.59 Cr | 1.14 Cr | 0.4175 | 0.00 Cr | 0.01 Cr | 0.87 Cr | 0.65 Cr | 2.12 | 0.88 Cr | 0.2381 |
| 2022-03-31 | 0.07 Cr | 0.00 Cr | 0.07 Cr | 0.9653 | 0.00 Cr | 0.01 Cr | -0.40 Cr | -0.01 Cr | -0.03 | -0.37 Cr | -0.1324 |
| 2021-03-31 | 0.21 Cr | 0.08 Cr | 0.13 Cr | 0.6052 | 0.00 Cr | 0.10 Cr | -0.31 Cr | -0.56 Cr | -1.83 | -0.13 Cr | -2.6867 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.02 Cr | 4.36 Cr | 0.46 Cr | 3.8982 Cr | 0.00 Cr | -0.02 Cr | 0.28 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.4579 Cr |
| 2024-03-31 | 0.00 Cr | 4.33 Cr | 0.79 Cr | 3.5421 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 0.7914 Cr |
| 2023-03-31 | 0.00 Cr | 4.42 Cr | 0.89 Cr | 3.5269 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.44 Cr | 0.8933 Cr |
| 2022-03-31 | 0.00 Cr | 3.80 Cr | 0.92 Cr | 2.8786 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.75 Cr | 0.00 Cr | 0.00 Cr | 0.40 Cr | 0.2143 Cr |
| 2021-03-31 | 0.00 Cr | 7.62 Cr | 3.13 Cr | 4.4880 Cr | 1.55 Cr | 1.55 Cr | 0.00 Cr | 6.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.8713 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.0272 Cr | 0.0120 Cr | 0.0000 Cr | 0.0180 Cr | 0.0392 Cr | 0.0452 Cr | -0.0092 Cr | 0.4414 Cr | 0.0000 Cr | 0.0000 Cr | -0.2842 Cr |
| 2024-03-31 | -0.0201 Cr | -0.0152 Cr | 0.0000 Cr | -0.0201 Cr | -0.0352 Cr | 0.0061 Cr | 0.0000 Cr | 0.0152 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | -0.7787 Cr | 1.5218 Cr | -0.7045 Cr | -0.7787 Cr | 0.0386 Cr | 0.0413 Cr | 0.0000 Cr | 0.6483 Cr | -0.7045 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | -2.1295 Cr | 3.6678 Cr | -1.5471 Cr | -2.1295 Cr | -0.0088 Cr | 0.0027 Cr | 0.0000 Cr | -0.0093 Cr | -1.5471 Cr | 0.0000 Cr | 0.0000 Cr |
| 2021-03-31 | 1.4847 Cr | -1.5793 Cr | 0.0683 Cr | -0.0946 Cr | -0.0263 Cr | 0.0115 Cr | -1.5793 Cr | -0.5591 Cr | 0.0683 Cr | 0.0000 Cr | 0.1240 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.22 Cr | 0.00 Cr | 0.22 Cr | 1.0000 | 0.15 Cr | 0.16 Cr | 0.51 | 0.16 Cr | 0.7059 |
| 2024-09-30 | 0.21 Cr | 0.00 Cr | 0.21 Cr | 1.0000 | 0.14 Cr | 0.15 Cr | 0.48 | 0.14 Cr | 0.7198 |
| 2024-06-30 | 0.16 Cr | 0.00 Cr | 0.16 Cr | 1.0000 | 0.13 Cr | 0.13 Cr | 0.42 | 0.13 Cr | 0.8214 |
| 2024-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | -0.04 Cr | -0.15 | -0.04 Cr | 0.0000 |
| 2023-12-31 | 0.04 Cr | 0.00 Cr | 0.04 Cr | 1.0000 | 0.02 Cr | 0.02 Cr | 0.07 | 0.02 Cr | 0.5579 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.00 Cr | 0.42 Cr | 0.42 Cr | 0.00 Cr | 0.00 Cr | 3.13 Cr | 0.01 Cr | 4.16 Cr | 0.34 Cr |
| 2024-06-30 | -0.01 Cr | 0.01 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | -3.54 Cr |
| 2024-03-31 | 0.00 Cr | 0.00 Cr | 0.01 Cr | 2.53 Cr | 0.00 Cr | 2.91 Cr | 0.00 Cr | 4.33 Cr | 0.79 Cr |
| 2023-12-31 | -0.04 Cr | 0.08 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.02 Cr | 0.02 Cr | 0.04 Cr | 1.03 Cr | 0.00 Cr | 5.44 Cr | 0.00 Cr | 6.80 Cr | 3.22 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -0.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-06-30 | 0.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹359.50 | ₹480,637,120,000.00 | ₹1,022,580.00 |
| Syngene International Limited | SYNGENE | ₹667.40 | ₹267,870,930,256.00 | ₹196,956.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹192.75 | ₹256,212,590,550.00 | ₹2,776,948.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,767.60 | ₹184,919,595,120.00 | ₹188,946.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹775.35 | ₹134,496,413,397.00 | ₹242,236.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹717.05 | ₹114,212,441,050.00 | ₹143,014.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹689.55 | ₹55,496,914,740.00 | ₹82,197.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹268.15 | ₹42,041,361,450.00 | ₹62,573.00 |
| Zota Health Care Limited | ZOTA | ₹1,269.70 | ₹38,227,365,780.00 | ₹33,784.00 |
Key Executives
Gender: male
Year Born: 1964
Gender: female
Year Born:
FAQs about Genomic Valley Biotech Ltd.
The CEO is Yogesh Agrawal.
The current price is ₹41.00.
The range is ₹39.5-94.
The market capitalization is ₹12.52 crores.
The P/E ratio is 32.37.
The company operates in the Healthcare sector.
Overview of Genomic Valley Biotech Ltd. (ISIN: INE574D01010) is a leading Biotechnology in India. With a market capitalization of ₹12.52 crores and an average daily volume of 1,929 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.